Below are two different viewpoints to challenge the corporate media hype. The first is to question what covid variant they claim to be testing for. The second describes covid as the rebranding of seasonal colds and flu – a rebranding that can be done time and time again to create an endless war.
Jill Biden tested positive for covid yesterday, just days before Joe Biden is due to travel to a Group of 20 summit in India. Her positive test is presumably to increase the hype about the new variant, and to get out of going to India. Joe has tested negative for covid so he still plans to make the trip.
Putting aside that covid tests cannot detect an infection, it would be interesting to know which covid variant the Biden’s were tested for.
According to the US Centres for Disease Control and Prevention (“CDC”) ‘Covid Data Tracker’ as of 2 September, EG.5 tops the list. Eris, or EG.5, doesn’t seem to be one of the more than 280 SAR-CoV-2 variants Sino Biological has in its bank.
Sino Biological, headquartered in Beijing and listed on the Shenzhen stock exchange, provides independently developed and produced recombinant proteins, antibodies and cDNA clones for basic, translational and clinical research.
The 280+ SARS-CoV-2 variants that Sino Biological has in its bank are, according to its Material Safety Data Sheet, “not to be used in humans. In the absence of any express written agreement to the contrary, products sold by Sino Biological, Inc. are for research use only.”
“For research use only” unless there
is a “written agreement.” What other use do commercially produced
SARS-CoV-2 variants have? We don’t know what regulations and oversight
there are on the buying and selling of virus components, especially the
disease-causing spike proteins, and we couldn’t find any obvious
controls stated on Sino Biological’s website. The selling of variants
without independent oversight is concerning enough but that Sino
Biologicals sells them for reasons other than research rings alarm
bells....<<<Read More>>>....